- Home
- ARVN vs DSGR Comparison
ARVN vs DSGR Comparison
Compare ARVN & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- DSGR
- Stock Information
- Founded
- ARVN 2015
- DSGR 1952
- Country
- ARVN United States
- DSGR United States
- Employees
- ARVN N/A
- DSGR N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- DSGR Industrial Machinery/Components
- Sector
- ARVN Health Care
- DSGR Industrials
- Exchange
- ARVN Nasdaq
- DSGR Nasdaq
- Market Cap
- ARVN 1.7B
- DSGR 1.8B
- IPO Year
- ARVN 2018
- DSGR N/A
- Fundamental
- Price
- ARVN $25.76
- DSGR $39.93
- Analyst Decision
- ARVN Strong Buy
- DSGR Buy
- Analyst Count
- ARVN 15
- DSGR 2
- Target Price
- ARVN $57.50
- DSGR $42.50
- AVG Volume (30 Days)
- ARVN 487.9K
- DSGR 57.4K
- Earning Date
- ARVN 10-30-2024
- DSGR 10-31-2024
- Dividend Yield
- ARVN N/A
- DSGR N/A
- EPS Growth
- ARVN N/A
- DSGR N/A
- EPS
- ARVN N/A
- DSGR N/A
- Revenue
- ARVN $93,300,000.00
- DSGR $1,699,770,000.00
- Revenue This Year
- ARVN $179.49
- DSGR $15.07
- Revenue Next Year
- ARVN N/A
- DSGR $9.57
- P/E Ratio
- ARVN N/A
- DSGR N/A
- Revenue Growth
- ARVN N/A
- DSGR 21.22
- 52 Week Low
- ARVN $13.57
- DSGR $22.91
- 52 Week High
- ARVN $53.08
- DSGR $41.47
- Technical
- Relative Strength Index (RSI)
- ARVN 50.68
- DSGR 62.56
- Support Level
- ARVN $25.42
- DSGR $39.45
- Resistance Level
- ARVN $29.24
- DSGR $41.47
- Average True Range (ATR)
- ARVN 1.24
- DSGR 0.93
- MACD
- ARVN 0.18
- DSGR 0.06
- Stochastic Oscillator
- ARVN 34.71
- DSGR 63.68
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.